(Update) Acalabrutinib in CLL and MCL
Acalabrutinib
Obinutuzumab
Zanubrutinib
Update Venetoclax in CLL
NCCN Guidelines for Patients for CLL
CLL Society
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
Cancer.gov